Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor commonly prescribed to manage hypertension and heart failure. By blocking the conversion of angiotensin I to angiotensin II, this medication… Read more









phosphinyl]acetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F123599-82-6-rel-2-R-1S-2-Methyl-1-1-oxopropoxypropoxy4-phenylbutylphosphinylacetic-Acid.png&w=3840&q=75)




Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor commonly prescribed to manage hypertension and heart failure. By blocking the conversion of angiotensin I to angiotensin II, this medication helps regulate blood pressure. It functions as a prodrug, undergoing in vivo metabolism to transform into its active form, fosinoprilat. To support pharmaceutical analysis, this category offers a comprehensive selection of reference standards. Laboratories rely on these compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled standards, for rigorous impurity profiling and method validation. These materials are essential for ensuring the accuracy of quality control protocols during the synthesis and formulation of the drug, enabling precise quantitative analysis throughout the drug development and manufacturing lifecycle.